Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

Economia

COMUNICATO STAMPA - Responsabilità editoriale di Business Wire

Biosafe Defenses LLC Announces a New Groundbreaking Disinfectant after 10 Years of Research

Business Wire

Biosafe Defenses LLC (formerly Biosafe Technologies LLC), the world leader in the creation of an entirely new class of light-activated disinfectants, antibacterials and biocides for the home, hospitals and industry, has just announced the receipt of a critical ninth US Patent, entitled “Conjugated Polyelectrolytes and Methods of Using the Same.” U.S. Patent No. 9,750,250 issued September 5, 2017. Canadian Patent No. 2,973,982 allowed August 14, 2017. European/Asian Patent Numbers to follow.

The Patent grants Biosafe Defenses a method of disinfecting an object using light-activated conjugated polyelectrolytes (CPEs), which thereby can inactivate and destroy molds, viruses, fungal yeast, and antibiotic-resistant bacteria. To perform this task, the Patent grants exclusivity to Biosafe Defenses to provide an antimicrobial substrate such as a wipe, tissue, bandage, medical device, surgical instrument, or even a textile that, when treated with Biosafe’s proprietary CPEs, delivers long-term protection against some of the world’s deadliest pathogens, long after bleaches have already lost their killing ability.

The technology envisions germ-killing clothing, or metals like surgical instruments or plastics such as the pull-down table of an airplane food tray, being coated with the technology, and thereafter enabling that object to kill bacteria or viruses on contact due to of the product’s light-activation technology. Diapers, sponges, countertops or food preparation surfaces could enjoy the same benefits. The hospital industry could especially benefit, as hospital-associated infections (HAIs) continue to be a growing concern for doctors, patients, and the cleaning staff who frequently fight to ward off multidrug-resistant strains that are often fatal.

“A better solution than bleaches or current disinfectants is needed, which Biosafe’s unique compounds can deliver,” said Biosafe CEO Dr. Harry Pappas. “This is a very important Patent for our company. The antimicrobials encompassed by this Patent are perhaps the most promising compounds in our library in that they are safe to use, yet still able to confer protection against even the most robust microbes. Several studies suggest that these compounds will perform very well in our anticipated EPA trials to come.”

ABOUT BIOSAFE DEFENSES LLC: Currently, the Company is in the process of developing a wipe which will deliver powerful disinfectant properties to everything that the wipe comes in contact with, from bed rails to door knobs and other germ carrying high contact surfaces. The company originated from technology jointly developed by The University of New Mexico and University of Florida funded by millions of dollars of Government research contracts over a ten-year span from the US Defense Threat Reduction Agency (DTRA). The company has recently emerged from “stealth mode” and is seeking global industry partners for various applications of its technology.

Website: www.biosafedefenses.com

Biosafe Defenses LLC
Harry Pappas Ph.D., CEO
1-508-259-7796 / 1-800-488-2001
hpappas@biosafedefenses.com

Permalink: http://www.businesswire.com/news/home/20170919005587/en

Video Economia


Vai al sito: Who's Who

Modifica consenso Cookie